I'm really fascinated by several things about this acquisition. 1. One could posit that APC business models in structural decline as they are replaced by transformative agreements. Will Hindawi titles be folded into Wiley TA's or offered as a separate "pure publish" model?
2. Seems that there is little concern about geopolitical risk: "Wiley…saw value in Hindawi’s strong position in Asia, the world’s largest and fastest growing academic publishing market…“Hindawi’s significant footprint in in China is a major benefit from that perspective”"
3. It seems some in the academic community continue to be "alarmed" when, after taking advantage of private capital to fund commercial start-ups for open access services (bepress; SSRN; now Hindawi), that capital looks to sell in search of returns. As if this is a surprise!
4. Most interesting will be to see how this expansion of Wiley's OA portfolio and platforms/workflows/services can connect with its important businesses in support of society publishing.
5. "Wiley anticipates achieving significant revenue synergies from the expansion of its open access journal portfolio and its beneficial impact on article cascade, added publishing capacity, and upsell opportunities for publishing and platform services." sec.report/Document/00001…
6. "If Zoom calls with MDPI and PLOS aren’t being scheduled now by Elsevier, Springer Nature, or Taylor & Francis, I’d be surprised." Maybe not literally PLOS as an NFP but definitely consolidation will continue apace. thegeyser.substack.com/p/wiley-contin…
7. Very important to recognize, as does @lorcanD, that both Wiley and Hindawi are not just publishers but also platform developers and providers:
Now, we will have a debate about preprints between @jessicapolka and @kanderson. I hope we will have less of a formal debate seeking a "winner" and more of an opportunity to learn about the array of issues. @_IanMoss is moderating. #STMAnnualUS
Polka shares "tremendous growth" of preprints, including new services some associated with incumbent publishers. #STMAnnualUS
Polka: A significant share of coronavirus research is being issued as preprints. And as preprints grow in significant, there are also valid concerns about malicious or invalid results. #STMAnnualUS
Elsevier's new CEO Kumsal Bayazit starting her opening plenary address at #ChsConf2019
Bayazit: "My hope and ambition for Elsevier is to work constructively with all the stakeholders in the system of research...and to evolve our services for the future." @chsconf2019
Bayazit: "It's clear there are serious issues and I want to use our time today to begin to address them." #chsconf2019
@lisalibrarian@paul_abrahams@bc_butler@acochran12733@CharlesOppenh Friends, I am not replying to any specific tweet here, just the latest in this long thread. I'm not familiar with the specific measure of market concentration that Paul points to. But perhaps I can offer some perspective to this conversation. 1/
@lisalibrarian@paul_abrahams@bc_butler@acochran12733@CharlesOppenh For academic libraries, bundles have been nearly irresistible, because of how they (& standalone journal titles) have been priced -- & bc of the principal-agent problem associated with buying on behalf of faculty members. This problem is compounded in a consortia negotiation. 3/
Now, ITHAKA president Kevin Guthrie interviews Elsevier chair YS Chi. #ithakatnw18
Guthrie: How do you square revenue with purpose in a commercial setting? Chi: You have to balance the two or you cannot persist. Sometimes it is a matter of timeline. Shareholders demand short term; Leaders must ensure longer term perspective. #ithakatnw18
Chi: We are trying to ask the market to be on a journey with us. If you want only short term returns, please do not own our shares. #ithakatnw18
Last week, the prospectus for Springer Nature's upcoming IPO was published. Some high level coverage appeared here for example. ft.com/content/1d43d9… I'm scanning the underlying document this afternoon and will post a few key excerpts.
"...cooperation with partners includes our long-standing business relationship with Digital Science...with respect to software for the simplification and streamlining of the research process." [page 57]
"Holtzbrinck Publishing Group may also compete with Springer Nature through its entity Digital Science, which is its strategic growth division investing in early stage ventures in the research and science industry. All the businesses of Digital Science are publisher agnostic..."